---
$id: https://graph.org.ai/products/commodity/51262304
$type: Product
source: UNSPSC
code: "51262304"
title: "Pirepolol"
class: "51262300"
classTitle: "Adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pirepolol

**UNSPSC Code**: 51262304
**Class**: [Adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines](Adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C21H32N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V1J0B4P41O, chemically known as (+-)-6-((2-((3-(p-butoxyphenoxy)-2-hydroxypropyl)amino)ethyl)amino)-1,3-dimethyluracil but generally known as pirepolol, which bears US NIH Compound Identifier 68887. European Medicines Agency schedules Pirepolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09905MIG. The term PIREPOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). PIREPOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pirepolol under HS 29335995 and SITC 51576. As of Q4 2014, PIREPOLOL remains the US FDA Preferred Term for this commodity. Pirepolol bears US NLM identifiers UMLS ID C1882394 and NCI Concept Code C66418. SMILES: O(CC(O)CNCCNC1N(C(=O)N(C(=O)C1)C)C)C1CCC(OCCCC)CC1.

